Split History
ETFs Holding NVLS »    NVLS Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Nivalis Therapeutics is a clinical stage pharmaceutical company engaged in the discovery, development and commercialization of product candidates for patients with cystic fibrosis (CF). Co.'s key product candidate, N91115, is a small molecule compound that addresses a defect in the cystic fibrosis transmembrane conductance regulator (CFTR), resulting from mutations in the CFTR gene, the underlying cause of CF. Co. is conducting a clinical trial in CF patients who have two copies of the F508del mutation, a type of CFTR mutation. This trial is designed to assess the efficacy and safety of N91115 in a triple therapy with two other CFTR modulators, lumacaftor/ivacaftor. According to our NVLS split history records, NVLS has had 3 splits.
NVLS split history picture
NVLS (NVLS) has 3 splits in our NVLS split history database. The first split for NVLS took place on August 22, 1990. This was a 2 for 1 split, meaning for each share of NVLS owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. NVLS's second split took place on October 14, 1997. This was a 2 for 1 split, meaning for each share of NVLS owned pre-split, the shareholder now owned 2 shares. For example, a 2000 share position pre-split, became a 4000 share position following the split. NVLS's third split took place on January 18, 2000. This was a 3 for 1 split, meaning for each share of NVLS owned pre-split, the shareholder now owned 3 shares. For example, a 4000 share position pre-split, became a 12000 share position following the split.

When a company such as NVLS splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the NVLS split history from start to finish, an original position size of 1000 shares would have turned into 12000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into NVLS shares, starting with a $10,000 purchase of NVLS, presented on a split-history-adjusted basis factoring in the complete NVLS split history. NVLS split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/07/2011
End date: 07/24/2017
Start price/share: $39.77
End price/share: $2.40
Dividends collected/share: $0.00
Total return: -93.97%
Average Annual Total Return: -35.59%
Starting investment: $10,000.00
Ending investment: $603.17
Years: 6.38
Date Ratio
08/22/19902 for 1
10/14/19972 for 1
01/18/20003 for 1
NVLS is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

NVO Split History
NVUS Split History
NWBO Split History
OBLN Split History
OCLS Split History
OCR Split History
OCRX Split History
OGEN Split History
OGXI Split History
OHRP Split History

Guardion Health Sciences, Inc. (GHSI)
China SXT Pharmaceuticals, Inc. (SXTC)
VYNE Therapeutics Inc. (VYNE)
The Sherwin-Williams Company (SHW)
Horizons US Marijuana Index ETF (HMUS)
MicroSectors FANG+ ETNs due January 8, 2038 (FNGS)
MicroSectors FANG+ Index 2X Leveraged ETNs due January 8, 2038 (FNGO)
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038 (FNGU)
Moleculin Biotech, Inc. (MBRX)
Exela Technologies, Inc. (XELA)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

NVLS Insider Buying

NVLS Split History | www.SplitHistory.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.